Viatris Specialty LLC

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 4 drugs with upcoming expirations

Activity

Key Events

Dec 16, 2025FDAViagra — VYBRIQUE

Jul 24, 2025FDANorvasc — SDAMLO

Dec 29, 2023TrialStudy of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Dec 29, 2023TrialStudy of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Apr 28, 2023FDAViagra — LIQREV

Feb 24, 2022FDANorvasc — NORLIQVA

Oct 4, 2021FDAZoloft — SERTRALINE HYDROCHLORIDE

Jul 27, 2021TrialStudy Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users

3 more events

Apr 30, 2021TrialStudy Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users

Mar 29, 2021TrialEvaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience

Jul 8, 2019FDANorvasc — KATERZIA

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

9 patent groups across drugs · Source: FDA Orange Book

DrugExpires

TobrexSep 12, 2028 NitrostatMar 12, 2029 TobrexNov 4, 2030 NitrostatMar 11, 2032 ViagraDec 16, 2033 Norvasc12 patentsOct 6, 2037 Viagra5 patentsDec 24, 2038 NorvascApr 11, 2039

1 more

Norvasc6 patentsFeb 24, 2041

Regulatory

Regulatory Timeline

20031 event

FDAOct 31

Norvasc — AMVAZ

Application NDA021435 (NDA)

20041 event

FDAJul 13

Tobrex — TOBRAMYCIN SULFATE

Application NDA050789 (NDA)

20052 events

FDAJun 3

Viagra — REVATIO

Application NDA021845 (NDA)

FDAFeb 22

Cardura — CARDURA XL

Application NDA021269 (NDA)

20061 event

FDANov 2

Nitrostat — NITROMIST

Application NDA021780 (NDA)

20071 event

FDASep 27

Norvasc — AMLODIPINE BESYLATE

Application NDA022026 (NDA)

20091 event

FDANov 18

Viagra — REVATIO

Application NDA022473 (NDA)

20112 events

FDAJun 21

Nitrostat — RECTIV

Application NDA021359 (NDA)

FDAJan 28

Neurontin — GRALISE

Application NDA022544 (NDA)

20122 events

FDAOct 12

Tobrex — BETHKIS

Application NDA201820 (NDA)

FDAAug 30

Viagra — REVATIO

Application NDA203109 (NDA)

20131 event

FDAMar 22

Tobrex — TOBI PODHALER

Application NDA201688 (NDA)

20141 event

FDADec 2

Tobrex — KITABIS PAK

Application NDA205433 (NDA)

20161 event

FDAJun 8

Nitrostat — GONITRO

Application NDA208424 (NDA)

20191 event

FDAJul 8

Norvasc — KATERZIA

Application NDA211340 (NDA)

20211 event

FDAOct 4

Zoloft — SERTRALINE HYDROCHLORIDE

Application NDA215133 (NDA)

20221 event

FDAFeb 24

Norvasc — NORLIQVA

Application NDA214439 (NDA)

20231 event

FDAApr 28

Viagra — LIQREV

Application NDA214952 (NDA)

20252 events

FDADec 16

Viagra — VYBRIQUE

Application NDA210858 (NDA)

FDAJul 24

Norvasc — SDAMLO

Application NDA219531 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)